The Enterprise Value as of September 2024 (TTM) for Acer Therapeutics Inc. (ACER) is 39.58M

According to Acer Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 39.58M. This represents a change of -13.10% compared to the average of 45.54M of the last 4 quarters.

Acer Therapeutics Inc. (ACER) Historical Enterprise Value (quarterly & annually)

How has ACER Enterprise Value performed in the past?

The mean historical Enterprise Value of Acer Therapeutics Inc. over the last ten years is 31.20M. The current 39.58M Enterprise Value has changed 12.59% with respect to the historical average. Over the past ten years (40 quarters), ACER's Enterprise Value was at its highest in in the September 2018 quarter at 229.91M. The Enterprise Value was at its lowest in in the June 2017 quarter at 3.21M.

Acer Therapeutics Inc. (ACER) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Acer Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Acer Therapeutics Inc. (ACER) Average Enterprise Value

How has ACER Enterprise Value performed in the past?

The current Enterprise Value of Acer Therapeutics Inc. (ACER) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Acer Therapeutics Inc. (ACER) Enterprise Value vs. Peers

How is ACER’s Enterprise Value compared to its peers?

Acer Therapeutics Inc.’s Enterprise Value is less than NRx Pharmaceuticals, Inc. (0), greater than Pasithea Therapeutics Corp. (24.97M), greater than SAB Biotherapeutics, Inc. (-3893252.00), greater than Lexaria Bioscience Corp. (13.76M), less than Navidea Biopharmaceuticals, Inc. (44.96M), greater than ZyVersa Therapeutics, Inc. (-2504975.00), greater than Biodexa Pharmaceuticals Plc (2.44M), greater than Oncorus, Inc. (-5427609.07), less than Kiromic BioPharma, Inc. (51.18M), greater than YS Biopharma Co., Ltd. (11.97M), less than BiomX Inc. (1.69B), greater than Avenue Therapeutics, Inc. (-5188847.00), greater than Hoth Therapeutics, Inc. (-925506.00), greater than Revelation Biosciences, Inc. (-2640895.00), greater than NeuroBo Pharmaceuticals, Inc. (-10595486.00), greater than Virax Biolabs Group Limited (1.43M), greater than null (8.97M),

Build a custom stock screener for Acer Therapeutics Inc. (ACER) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Acer Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Acer Therapeutics Inc. (ACER) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Acer Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.